US Stock MarketDetailed Quotes

FATE Fate Therapeutics

Watchlist
  • 1.800
  • +0.010+0.56%
Close Jan 3 16:00 ET
  • 1.840
  • +0.040+2.22%
Pre 07:35 ET
205.01MMarket Cap-1.10P/E (TTM)

About Fate Therapeutics Company

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.

Company Profile

SymbolFATE
Company NameFate Therapeutics
Listing DateOct 1, 2013
Issue Price6.00
Founded2007
CEODr. Bahram Valamehr, M.B.A.,PhD
MarketNASDAQ
Employees220
Fiscal Year Ends12-31
Address12278 Scripps Summit Drive
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92131
Phone1-858-875-1800
Websitehttp://www.fatetherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Bahram Valamehr, M.B.A.,PhD
  • Director, President, Chief Executive Officer, Principal Financial Officer and Principal Accounting Officer
  • 2.99M
  • Cindy Tahl
  • Chief Legal and Compliance Officer
  • 2.82M
  • Dr. John D. Mendlein, J.D.,PhD
  • Vice Chairman of the Board
  • 218.33K
  • Dr. William H. Rastetter,PhD
  • Chairman of the Board
  • 253.25K
  • Dr. Neelufar Mozaffarian, F.A.C.R.
  • Director
  • --
  • Dr. Robert S. Epstein, M.D.,M.S.
  • Independent Director
  • 228.25K
  • Michael Lee
  • Independent Director
  • 216.75K
  • Dr. Shefali Agarwal, M.D.,M.P.H.
  • Independent Director
  • 227.75K
  • Timothy P. Coughlin
  • Independent Director
  • 231.75K
  • Dr. Karin Jooss, PhD
  • Independent Director
  • 227.82K
  • Dr. Yuan Xu, PhD
  • Independent Director
  • 228.60K
  • Dr. Robert M. Hershberg, M.D.,PhD
  • Independent Director
  • 221.75K
Heat List
US
Overall
Symbol
Price
% Chg

No Data